Posts tagged with "(NASDAQ:MNKD)"

MannKind Corporation (NASDAQ:MNKD)’s VP offloads 20,000 shares

Posted by George Brook August 29, 2013 0 Comment 5640 views

In a transaction that was dated 26 August, MannKind Corporation (NASDAQ:MNKD)’s vice-president, Juergen Martens off-loaded 20,000 shares of the company in the open market. The shares were sold at an average-price of $5.52 and the total transaction value was $110,400.00. Post completion of this transaction, the VP now directly-owns 136,016 shares in MNKD. This sale […]

MannKind Corporation (NASDAQ:MNKD) entrenched firmly in second Tranche of financing

Posted by Samantha Donahue August 20, 2013 0 Comment 1492 views

The MannKind Corporation (NASDAQ:MNKD) has announced that as per the agreement to the 1 July 2013, facility contract, between MNKD and the Deerfield Private Design Fund II. L.P, the conditions or the terms that obligate Deerfield to buy the 2nd tranche worth $40M of 9.75% senior-secured Convertible Notes, have been met now. The 2nd tranche […]

MannKind Corporation (NASDAQ:MNKD)’s Afrezza report raises ratings

Posted by Peter Lauro August 19, 2013 0 Comment 1253 views

The California-based MannKind Corporation (NASDAQ:MNKD) has received a much-required $40M finance from Deerfield post the data readout. This is the 2nd of the 4 trances that are supposed to provide the company with a total of $160 million. In a statement, the company said that the 2nd trance of convertible notes would depend on the […]

MannKind Corporation (NASDAQ:MNKD) has a one-of-a-kind product

Posted by Peter Lauro August 16, 2013 0 Comment 2187 views

MannKind Corporation (NASDAQ:MNKD) stock dipped by 12.52% in Thursday’s trading. The opening price of $7.06 touched an intraday high of $7.18 which dropped to a close of $6.64. More than 19.45 million shares were traded in Thursday while the average volume of shares over a 30-day buy viagra period was $9.35M. The company has a […]

MannKind Corporation (NASDAQ:MNKD)’s AFREZZA: one of its kind

Posted by Beth Hart June 20, 2013 0 Comment 1223 views

Recently, MannKind Corporation (NASDAQ:MNKD) completed a phase-III study on Afrezza, its diabetes candidate. All the follow-up visits for the patients who had enrolled in the study, were completed. MNKD expects to publish all the data from the study towards the end of summer. The open-label phase-III study evaluated the inhalation powder, Afrezza in patients who […]

Mannkind Corporation (NASDAQ:MNKD) to present at the healthcare conference

Posted by Nathan Alexander June 12, 2013 0 Comment 1286 views

Mannkind Corporation (NASDAQ:MNKD) primarily engaged in the development and commercialization of therapeutic products for the treatment of diseases such as diabetes and cancer. The development stage bio pharmaceutical company had completed the Phase III clinical trials for its drug candidate AFREZZA, which had been developed as an ultra rapid action meal time insulin inhalation powder. […]

MannKind Corporation (NASDAQ:MNKD) – One of its kind in insulin development

Posted by Beth Hart June 4, 2013 0 Comment 2291 views

On 31 May MannKind Corporation (NASDAQ:MNKD) announced the completion of all the follow-up visits for patients who had been enrolled Study 171 in the Phase III clinical study of AFREZZA® inhalation powder. This is an investigational, rapid-acting, mealtime insulin therapy. It will be administered using the company’s next-generation inhaler.  The inhalation powder is based on […]

MannKind Corporation (NASDAQ:MNKD) shares surged by 2.75%, Alcoa Inc (NYSE:AA)

Posted by Lacee Page May 29, 2013 0 Comment 1594 views

MannKind Corporation (NASDAQ:MNKD): Tuesday’s trading session saw MannKind Corporation (NASDAQ:MNKD) rising by 2.75%. The opening price of $6.36 climbed to an intraday high of $6.79 before settling down to close at $6.36 per share. Around 8.65 million shares were traded in the last trading session, which stood above the average volume of 6.71 million that […]

MannKind Corporation (NASDAQ:MNKD) shares increasing rapidly, Alcoa Inc (NYSE:AA)

Posted by Lacee Page May 28, 2013 0 Comment 2161 views

MannKind Corporation (NASDAQ:MNKD): In Friday’s trading session, MannKind Corporation (NASDAQ:MNKD) dipped 4.38%. The opening price of $6.78 was the intraday high as well, which eventually headed down to close at $6.26 per share. Over 13.79 million shares exchanged hands in the last trading session. This number stood below the average volume of 6.71 million that […]

Saks Inc (NYSE:SKS) hires Goldman Sachs Group, Inc, MannKind Corporation (NASDAQ:MNKD)

Posted by Steve Raasch May 24, 2013 0 Comment 1969 views

Saks Inc (NYSE:SKS): Thursday’s trading session saw Saks Inc (NYSE:SKS) down by 0.06% and closed at $15.49. It opened at a price of $15.56 which touched an intraday high of $15.77, before moving down to close at $15.39 per share. In the previous day’s trading session, around 6.77 million shares were traded. This number was […]